GuestSeminars
Room TBA & Zoom session
Add to Calendar 2026-06-22 11:00:00 2026-06-22 12:00:00 GuestSeminars@UCIBIO | Bruno Sainz Advances in understanding pancreatic cancer: from bench to preclinical models Bruno Sainz, Sols-Morreale Institute for Biomedical Research (IIBM), CSIC-UAM, Spain   Host: Alexandra Fernandes, UCIBIO NOVA   Online Link: https://ucibio.pt/l/GuestSeminars     Short-bio: Dr. Sainz earned his PhD in Microbiology and Immunology from Tulane University in the USA in 2015 and is currently a Group Leader at the Sols-Morreale Institute for Biomedical Research (IIBM), which is a joint CSIC-UAM center. He is also co-coordinator of Area 3 (Cancer) at the Ramón y Cajal Institute for Health Research (IRYCIS). He leads both the Cancer Stem Cells and Fibroinflammatory Microenvironment at the IIBM and the Biomarkers and Personalized Approach to Cancer Group (BioPAC) at the IRYCIS, where his teams focus on cancer stem cells in pancreatic cancer and personalised approaches to treating PDAC. Dr. Sainz’s accomplishments and the work of his laboratory have resulted in more than 110 publications in journals like Gut, Cancer Cell, Nature Communications, Nature Medicine, etc, as well as multiple national and international grants and several patents. Room TBA & Zoom session UCIBIO info@simbiose.com Europe/Lisbon public
bruno sainz

Advances in understanding pancreatic cancer: from bench to preclinical models

Bruno Sainz, Sols-Morreale Institute for Biomedical Research (IIBM), CSIC-UAM, Spain

 

Host: Alexandra Fernandes, UCIBIO NOVA

 

Online Link: https://ucibio.pt/l/GuestSeminars

 

 

Short-bio:

Dr. Sainz earned his PhD in Microbiology and Immunology from Tulane University in the USA in 2015 and is currently a Group Leader at the Sols-Morreale Institute for Biomedical Research (IIBM), which is a joint CSIC-UAM center. He is also co-coordinator of Area 3 (Cancer) at the Ramón y Cajal Institute for Health Research (IRYCIS). He leads both the Cancer Stem Cells and Fibroinflammatory Microenvironment at the IIBM and the Biomarkers and Personalized Approach to Cancer Group (BioPAC) at the IRYCIS, where his teams focus on cancer stem cells in pancreatic cancer and personalised approaches to treating PDAC. Dr. Sainz’s accomplishments and the work of his laboratory have resulted in more than 110 publications in journals like Gut, Cancer Cell, Nature Communications, Nature Medicine, etc, as well as multiple national and international grants and several patents.

GuestSeminars@UCIBIO | Bruno Sainz